Priority Date: 30.08.11 (IN 2011MUM2424)

1,6- DIAZABICYCLO [3,2,1]OCTAN- 7 - ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS

  • Application ID: EP12772809
  • Status: PATENT GRANTED

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
1 office
active in Legal Services
Employment test 201 - 500 employees
Company dna nlo
operating since 1888
Headquarter in The Hague and 3 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). MayReiprich Patentanwälte is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 190 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 30.08.2011 - Priority Date (IN 2011MUM2424)
  • 07.03.2013 - Publication A1 (WO2013030735)
  • 20.05.2015 - Publication A1 (EP2872510)
  • 23.11.2016 - Publication B1 (EP2872510)

IPC Classification